Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)

NCT04198805 is registered in ClinicalTrials.gov with Naga P. Chalasani as lead sponsor.

NCT NCT04198805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04198805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Lead sponsor
Naga P. Chalasani
Phase
Phase 2
Overall status
Completed
Start date
January 3, 2020
Completion date
September 1, 2022
Enrollment
205 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis